Deep learning model to predict Epstein-Barr virus associated gastric cancer in histology.

Journal: Scientific reports
PMID:

Abstract

The detection of Epstein-Barr virus (EBV) in gastric cancer patients is crucial for clinical decision making, as it is related with specific treatment responses and prognoses. Despite its importance, the limited medical resources preclude universal EBV testing. Herein, we propose a deep learning-based EBV prediction method from H&E-stained whole-slide images (WSI). Our model was developed using 319 H&E stained WSI (26 EBV positive; TCGA dataset) from the Cancer Genome Atlas, and 108 WSI (8 EBV positive; ISH dataset) from an independent institution. Our deep learning model, EBVNet consists of two sequential components: a tumor classifier and an EBV classifier. We visualized the learned representation by the classifiers using UMAP. We externally validated the model using 60 additional WSI (7 being EBV positive; HGH dataset). We compared the model's performance with those of four pathologists. EBVNet achieved an AUPRC of 0.65, whereas the four pathologists yielded a mean AUPRC of 0.41. Moreover, EBVNet achieved an negative predictive value, sensitivity, specificity, precision, and F1-score of 0.98, 0.86, 0.92, 0.60, and 0.71, respectively. Our proposed model is expected to contribute to prescreen patients for confirmatory testing, potentially to save test-related cost and labor.

Authors

  • Yeojin Jeong
    Genome & Health Data Lab, School of Public Health, Seoul National University, Seoul, Korea.
  • Cristina Eunbee Cho
    Department of Convergence Medicine, Asan Institute of Life Science, University of Ulsan College of Medicine, Asan Medical Center, Seoul, 05505, Korea.
  • Ji-Eon Kim
    Medical Convergence Research Center, Wonkwang University Hospital, Jeollabuk-do, Republic of Korea.
  • Jonghyun Lee
    Civil and Environmental Engineering, University of Hawaii at Manoa, Honolulu, HI 96822, USA; Water Resources Research Center, University of Hawaii at Manoa, Hawaii, HI 96822, USA. Electronic address: jonghyun.harry.lee@hawaii.edu.
  • Namkug Kim
    Department of Radiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
  • Woon Yong Jung
    Department of Pathology, Hanyang University Guri Hospital, Hanyang University College of Medicine, Guri, Republic of Korea.
  • Joohon Sung
    Genome & Health Data Lab, School of Public Health, Seoul National University, Seoul, Korea. jsung@snu.ac.kr.
  • Ju Han Kim
    Department of Cardiovascular Medicine, Chonnam National University Hospital, Gwangju, Korea.
  • Yoo Jin Lee
    Department of Internal Medicine.
  • Jiyoon Jung
    Department of Pathology, Kangnam Sacred Heart Hospital, College of Medicine, Hallym University, Seoul, Republic of Korea.
  • Juyeon Pyo
    Department of Pathology, International St. Mary's Hospital, Catholic Kwandong University College of Medicine, Incheon, Republic of Korea.
  • Jisun Song
    Department of Pathology, Ewha Womans University Seoul Hospital, Ewha Womans University College of Medicine, Seoul, Republic of Korea.
  • Jihwan Park
    School of Software Convergence, College of Software Convergence, Dankook University, Korea.
  • Kyoung Min Moon
    Department of Pulmonary, Allergy, and Critical Care Medicine, Gangneung Asan Hospital, College of Medicine, University of Ulsan, 38, Bangdong-gil, Sacheon-myeon, Gangneung-si, 25440, Gangwon-do, Republic of Korea. pulmogicu@ulsan.ac.kr.
  • Sangjeong Ahn
    Division of Biomedical Informatics, Seoul National University College of Medicine, Seoul National University Biomedical Informatics (SNUBI), Seoul, Republic of Korea. vanitasahn@gmail.com.